Sign up to save tools and stay up to date with the latest in AI
bg
bg
1

BioConnect Launches the Arc Series: Biometric Devices for Zero Trust Authentication

Jan 08, 2025 - financialpost.com
BioConnect has launched the Arc Series, a new line of biometric devices designed for zero trust authentication, aimed at enhancing security, compliance, and scalability for enterprises and data centers. The series includes three devices: Arc Vision, a facial authentication device; Arc Touch, a fingerprint authentication device; and Arc Rex, an advanced multi-modal facial authentication device set to release in September 2025. These devices, powered by AI technology, offer features such as rapid and accurate authentication, compliance with global privacy standards, and durability in extreme conditions. The Arc Series integrates seamlessly with existing access control systems, eliminating the need for costly installations.

The Arc Series is part of BioConnect's commitment to setting new standards in biometric access control, providing organizations with tools to safeguard people, data, and assets. Key features include automatic biometric enrollment, which uses existing profile images for user enrollment, and compliance with standards like GDPR and ISO 27001. The devices are now available for purchase, and BioConnect aims to deliver a comprehensive solution combining innovation, security, and scalability.

Key takeaways:

  • BioConnect has launched the Arc Series, a new line of biometric devices for zero trust authentication, including Arc Vision, Arc Touch, and Arc Rex.
  • The Arc Series is designed to meet the evolving security, compliance, and scalability needs of enterprises and data centers.
  • Key features include advanced AI-powered biometric technology, privacy-first design compliant with global standards, and seamless integration with existing access control systems.
  • The Arc Series is now available for purchase, offering a comprehensive solution that combines innovation, security, and scalability.
View Full Article

Comments (0)

Be the first to comment!